Marijuana in Combination With Opioids in Palliative and Hospice Patients

• Status: Enrolling by invitation
• Trial end date: 2021-11-30
• Target enrollment: 0
• Participant gender: All

Summary

Study Objectives: Primary reduction of pain and reduction in overall opioid utilization. Secondary improvement in overall patient well being, weight stabilization with increased appetite, improved oxygen saturation, improvement or prevention of nausea and vomiting.

Study Rationale: To determine optimum use and dosing of medical marijuana (CBD:THC) for pain and symptom management.

Study Population: This study specifically will enroll cancer and non-cancer patients as a primary diagnosis suffering from pain and having a terminal illness (defined as having less than 6 months to live) requiring end of life care.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Connecticut Hospice Inc.
• Treatments: Analgesics, Opioid; Cannabidiol

Criteria

Inclusion Criteria:

• Age > 18

• Alert adults

• requiring opioids for pain management (routine or as needed)

• cancer diagnosis or non-cancer diagnosis as their terminal illness

Exclusion Criteria:

• pregnant women

• Age < 18

• minimally or unresponsive patients unable to take oral medications

• agitated combative patients